Christopher James analyst

Currently out of the existing stock ratings of Christopher James, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Christopher James

Work Performance Price Targets & Ratings Chart

Analyst Christopher James, carries an average stock price target met ratio of 60% that have a potential upside of 47.66% achieved within 316 days. Previously, Christopher James worked at LADENBURG, B. RILEY.

Christopher James’s has documented 29 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ACHN, Achillion Pharmaceuticals at 12-Sep-2017.

Wall Street Analyst Christopher James

Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 7/18/2017. The price target of $20 was fulfilled within 79 days with a profit of $7.59 (61.16%) receiving and performance score of 7.74.

Average potential price target upside

ACHN Achillion Pharmaceuticals ALNY Alnylam Pharmaceuticals CORT Corcept Therapeutics TRVN Trevena ZFGN Zafgen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2

$1.82 (1011.11%)

$5

5 years 11 months 3 days ago
(03-May-2019)

2/3 (66.67%)

$-0.96 (-32.43%)

528

Hold

$4

7 years 1 months 29 days ago
(08-Feb-2018)

4/4 (100%)

$-0.81 (-16.84%)

106

Buy

$5

$4.82 (2677.78%)

$6

7 years 3 months 26 days ago
(11-Dec-2017)

0/4 (0%)

$2.14 (74.83%)

Buy

$10

7 years 6 months 25 days ago
(12-Sep-2017)

0/2 (0%)

$5.79 (137.53%)

Hold

$4

$3.82 (2122.22%)

$5

7 years 6 months 26 days ago
(11-Sep-2017)

6/7 (85.71%)

$0.17 (4.44%)

49

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Christopher James?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?